title: Effectiveness of the gold standard programmes (GSP) for smoking cessation in pregnant and non-pregnant women.
abstract: BACKGROUND
  Smoking is considered the most important preventable risk factor in relation to the development of complications during pregnancy and delivery. The aim of this study was to evaluate the effectiveness of an intensive 6-week gold standard programme (GSP) on pregnant women in real life.
  
  
  METHODS
  This was a prospective cohort study based on data from a national Danish registry on smoking cessation interventions. The study population included 10,682 women of a fertile age. The pregnancy status of the study population was identified using the National Patient Registry.
  
  
  RESULTS
  The response rate to follow up was 76%. The continuous abstinence rate for both pregnant and non-pregnant smokers was 24-32%. The following prognostic factors for continuous abstinence were identified: programme format (individual/group), older age, heavy smoking, compliance with the programme, health professional recommendation, and being a disadvantaged smoker.
  
  
  CONCLUSIONS
  The GSP seems to be as effective among pregnant smokers as among non-pregnant smoking women. Due to the relatively high effect and clinical significance, the GSP would be an attractive element in smoking cessation intervention among pregnant women.
authors: WHO-CC Clinical Health Promotion Centre, Bispebjerg and Frederiksberg Hospitals--a part of Copenhagen University Hospital, The Capital Region, Nordre Fasanvej 57, DK-2000 Frederiksberg, Copenhagen, Denmark. mette.rasmussen.03@regionh.dk
authors: Mette
authors: M
authors: Rasmussen
authors: Berit Lilienthal
authors: BL
authors: Heitmann
authors: Hanne
authors: H
authors: Tønnesen
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D011247:Pregnancy; D015397:Program Evaluation; D011446:Prospective Studies; D012907:Smoking; D016540:Smoking Cessation; D055815:Young Adult
references: Acta Obstet Gynecol Scand. 2008;87(7):760-7
references: 18696277
references: Addiction. 2005 Mar;100(3):299-303
references: 15733243
references: Addiction. 2013 Sep;108(9):1680-5
references: 23668684
references: Lancet. 2012 Dec 15;380(9859):2095-128
references: 23245604
references: Clin Respir J. 2010 Jan;4(1):3-12
references: 20298412
references: Nicotine Tob Res. 2004 Apr;6 Suppl 2:S189-202
references: 15203821
references: Nicotine Tob Res. 2004 Apr;6 Suppl 2:S125-40
references: 15203816
references: Addiction. 2005 Apr;100 Suppl 2:46-58
references: 15844289
references: Can J Public Health. 2013 Jan 07;104(1):e69-74
references: 23618121
references: Ir Med J. 2012 Apr;105(4):105-8
references: 22708221
references: Am J Public Health. 2008 Feb;98(2):317-22
references: 18172143
references: Drug Alcohol Depend. 2013 Oct 1;132(3):660-4
references: 23680076
references: Tob Control. 2013 Nov;22(6):e9
references: 22705716
references: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001055
references: 19588322
references: Pediatrics. 1999 Oct;104(4):e46
references: 10506271
references: BMJ. 2007 Oct 20;335(7624):806-8
references: 17947786
references: Drug Alcohol Rev. 2010 Jan;29(1):81-90
references: 20078687
references: Addiction. 2005 Apr;100 Suppl 2:59-69
references: 15755262
references: Am J Perinatol. 2009 Apr;26(4):279-86
references: 19021090
references: J Public Health (Oxf). 2011 Mar;33(1):39-47
references: 21178184
references: Scand J Public Health. 2005;33(2):138-45
references: 15823975
references: BJOG. 2012 Aug;119(9):1029-39
references: 22780818
references: Lancet. 2012 Dec 15;380(9859):2224-60
references: 23245609
references: Int J Environ Res Public Health. 2013 Sep 09;10(9):4186-99
references: 24022655
references: Br J Addict. 1991 Sep;86(9):1119-27
references: 1932883
references: Am J Epidemiol. 2001 Aug 15;154(4):322-7
references: 11495855
references: Semin Neonatol. 2000 Aug;5(3):231-41
references: 10956448
references: Arch Dis Child. 2000 Sep;83(3):203-6
references: 10952633